Atlas Trials

HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity

Clinical trial NCT07586215 · RECRUITING

Trial details

NCT number
NCT07586215
Sponsor
Fudan University
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer Metastatic
Start date
2024-11-11
Primary completion
2026-11-11
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.